ARHGEF10 and neuromuscular disease: These studies demonstrated coimmunoprecipitation of TRPV4WT and ARHGEF10 and confirmed reduced interaction of ARHGEF10 with the two neuromuscular disease-causing mutants (Fig. 5, C and D).